Axsome Therapeutics, Inc. 10-Q filing
Filed 2025-08-04 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-102148
- Form type
- 10-Q
- CIK
- 0001579428
- Primary document
- https://www.sec.gov/Archives/edgar/data/1579428/000095017025102148/axsm-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Axsome Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $271.5M | - | - |
| Operating Income | $-93.7M | - | - |
| Net Income | $-107.4M | - | - |
| Eps Basic | -2.18 | - | - |
| Eps Diluted | -2.18 | - | - |
| Cash And Equivalents | $303.0M | - | - |
| Total Assets | $639.8M | - | - |
| Total Liabilities | $566.7M | - | - |
| Shareholders Equity | $73.1M | - | - |
| Operating Cash Flow | $-75.8M | - | - |
| Capital Expenditures | $351,000 | - | - |